Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bernadett FARKAS"'
Autor:
Laszlo J. Barkai, Lorant Gonczi, Fruzsina Balogh, Dorottya Angyal, Klaudia Farkas, Bernadett Farkas, Tamas Molnar, Tamas Szamosi, Eszter Schafer, Petra A. Golovics, Mark Juhasz, Arpad Patai, Aron Vincze, Patricia Sarlos, Alexandra Farkas, Zsolt Dubravcsik, Tamas G. Toth, Hajnal Szekely, Pal Miheller, Peter L. Lakatos, Akos Ilias
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Long-term data on ustekinumab in real-life Crohn’s disease patients are still missing, though randomized controlled trials demonstrated it as a favorable therapeutic option. We aimed to evaluate ustekinumab's clinical efficacy, drug sustai
Externí odkaz:
https://doaj.org/article/18a9d3318eab411daa58056039b17d6c
Autor:
Péter Bacsur, Tamás Resál, Patrícia Sarlós, Ákos Iliás, Liza Dalma Sümegi, Diána Kata, Anett Dávid, Bernadett Farkas, Emese Ivány, Anita Bálint, Zsófia Bősze, Anna Fábián, Renáta Bor, Zoltán Szepes, Waqqas Afif, Talat Bessissow, Klaudia Farkas, Péter L. Lakatos, Tamás Molnár
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: The usability of subcutaneous vedolizumab (s.c. VDZ) treatment in inflammatory bowel diseases (IBD; ulcerative colitis (UC), Crohn’s disease (CD)) has been proven via clinical trials while real-world data collection is ongoing. Objectiv
Externí odkaz:
https://doaj.org/article/c22a45855e894d3eb5843d9997f140aa
Autor:
Péter Bacsur, Tamás Resál, Bernadett Farkas, Boldizsár Jójárt, Zoltán Gyuris, Gábor Jaksa, Lajos Pintér, Bertalan Takács, Sára Pál, Attila Gácser, Kata Judit Szántó, Mariann Rutka, Renáta Bor, Anna Fábián, Klaudia Farkas, József Maléth, Zoltán Szepes, Tamás Molnár, Anita Bálint
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2100 (2024)
Alterations to intestinal microbiota are assumed to occur in the pathogenesis of inflammatory bowel disease (IBD). This study aims to analyze the association of fecal microbiota composition, body composition, and lipid characteristics in patients wit
Externí odkaz:
https://doaj.org/article/fe40db87fa674bcc96e21d1bca3d7362
Autor:
Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál, Emese Földi, Béla Vasas, Bernadett Farkas, Mariann Rutka, Talat Bessissow, Waqqas Afif, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, Klaudia Farkas, Peter L Lakatos, Tamás Molnár
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Different endoscopic scoring systems for assessing ulcerative colitis (UC) severity are available. However, most of them are not correlated with disease extent. Objectives: Our study aimed to compare the predictive value of the PanMay sco
Externí odkaz:
https://doaj.org/article/3145a2041e99493e847d9a692c64d678
Publikováno v:
Journal of Central European Agriculture, Vol 22, Iss 2, Pp 420-428 (2021)
The use of pesticides dominates agriculture today, but unfortunately poses several threats to the environment and humans, through bioaccumulation and biomagnification. This research tested the efficacies of Salvia officinalis subsp. lavandulifolia an
Externí odkaz:
https://doaj.org/article/47e2216b58384c90b9942f3c1f7dcd16
Publikováno v:
Journal of Central European Agriculture, Vol 22, Iss 2, Pp 420-428 (2021)
Journal of Central European Agriculture
Volume 22
Issue 2
Journal of Central European Agriculture
Volume 22
Issue 2
The use of pesticides dominates agriculture today, but unfortunately poses several threats to the environment and humans, through bioaccumulation and biomagnification. This research tested the efficacies of Salvia officinalis subsp. lavandulifolia an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f10441b5f06d8756a00f299ac36d0be
https://jcea.agr.hr/articles/772703_Antifungal_activity_of_Salvia_officinalis_subsp_lavandulifolia_and_Salvia_officinalis_subsp_major_aqueous_extracts_against_en.pdf
https://jcea.agr.hr/articles/772703_Antifungal_activity_of_Salvia_officinalis_subsp_lavandulifolia_and_Salvia_officinalis_subsp_major_aqueous_extracts_against_en.pdf